| abstract |
The present invention provides a therapeutically effective amount of a composition comprising in a lysosomal storage disease patient at least one protease or peptidase, an amount sufficient to improve, reduce or ameliorate at least one symptom of the disease. Methods and compositions for treating patients with lysosomal storage diseases such as Gaucher disease. The present invention also provides a dietary supplement for patients with lysosomal storage diseases. |